Related Experiment Video
Updated: May 28, 2026
14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
FOOPAS Study: Functional Assessment and Prognostic Value in Aortic Valve Replacement for Patients ≥ 75 Years.
Dennis Eckner1, Susanne Wicklein2, Markus Gosch2
1Department of Cardiology, Klinikum Nürnberg Paracelsus Medical University Nuremberg, 90471 Nuremberg, Germany.
Journal of Clinical Medicine
|May 27, 2026
Summary
Geriatric assessment results, including age and frailty, influence heart team decisions for aortic stenosis interventions like transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). A combination of scores, not single tools, best predicts mortality risk.
Area of Science:
- Cardiology
- Geriatrics
Background:
- Increasing number of older patients undergoing cardiac interventions due to demographic shifts.
- Aortic valve stenosis is the primary indication, managed via surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI).
- Investigating the impact of geriatric assessment on intervention choices for aortic stenosis.
Purpose of the Study:
- To determine if geriatric assessment findings influence the heart team's decision-making process for aortic stenosis interventions.
- To evaluate the association between geriatric assessment results and the choice between TAVI, SAVR, or conservative management.
- To assess the predictive value of geriatric assessment tools for one-year mortality in this patient cohort.
Main Methods:
- Single-center, prospective, longitudinal case-control study over 12 months.
- Patients underwent risk stratification and clinical evaluation before assignment to TAVI, SAVR, or conservative management.
- Cardiological evaluation and comprehensive geriatric assessment were performed.
Main Results:
- Out of 135 patients (mean age 81 years), 60% received TAVI, 29% SAVR, and 11% conservative therapy.
- Age, Frailty Score, cognition, and nutritional status significantly correlated with the heart team's intervention choice.
- EuroSCORE II was the sole independent predictor of one-year mortality (OR 1.58); overall one-year mortality was 9.9%.
Conclusions:
- Individual geriatric assessment tools were insufficient for predicting mortality.
- A multimodal approach combining various assessment scores is recommended for accurate mortality risk assessment in patients with aortic stenosis.
- Geriatric assessment plays a role in guiding intervention decisions for aortic stenosis in the elderly population.
Related Concept Videos
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:17Aortic Regurgitation IV: Nursing Management
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...